South Korea's Enzychem To Make Cadila's COVID-19 Shot

South Korea's Enzychem Lifesciences would make at least 80 million doses of India's homegrown DNA COVID-19 vaccine from Cadila Healthcare, the Indian drugmaker said on Wednesday.

from NDTV News - Latest https://ift.tt/3DNpCYA